Circulating miR-221/222 reduces CD4+ T cells by inhibiting CD4 expression in colorectal cancer

Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness

(2019) Beatrix Bencsikova et al.   BMC CANCER

Prognostic Role of miR-221 and miR-222 Expression in Cancer Patients: A Systematic Review and Meta-Analysis

(2019) Gloria Ravegnini et al.   Cancers

miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells

(2019) Junko Mukohyama et al.   CANCER RESEARCH

Non-coding RNAs as biomarkers for acute myocardial infarction

(2018) Chen Wang et al.   ACTA PHARMACOLOGICA SINICA

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

(2018) Franck Pagès et al.   LANCET

Lineage tracking reveals dynamic relationships of T cells in colorectal cancer

(2018) Lei Zhang et al.   NATURE

Impact Of Circulating T Helper 1 And 17 Cells in the Blood on Regional Lymph Node Invasion in Colorectal Cancer

(2017) Ji Yeon Lee et al.   Journal of Cancer

Regulatory T Cells from Colon Cancer Patients Inhibit Effector T-cell Migration through an Adenosine-Dependent Mechanism

(2016) P. Sundstro m et al.   Cancer Immunology Research

FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer

(2015) Changhua Zhuo et al.   IMMUNOLOGIC RESEARCH

Circulating plasma microRNAs as a screening method for detection of colorectal adenomas

(2015) Ajay M Verma et al.   LANCET

Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis

(2015) Kenta Baba   WORLD JOURNAL OF GASTROENTEROLOGY

microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma

(2014) T O Yau et al.   BRITISH JOURNAL OF CANCER

A microRNA 221– and 222–Mediated Feedback Loop Maintains Constitutive Activation of NFκB and STAT3 in Colorectal Cancer Cells

(2014) Sanhong Liu et al.   GASTROENTEROLOGY

Decreased Levels of miR-224 and the Passenger Strand of miR-221 Increase MBD2, Suppressing Maspin and Promoting Colorectal Tumor Growth and Metastasis in Mice

(2013) Kefei Yuan et al.   GASTROENTEROLOGY

A colorectal cancer classification system that associates cellular phenotype and responses to therapy

(2013) Anguraj Sadanandam et al.   NATURE MEDICINE

MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma

(2011) Kai Sun et al.   ACTA PHARMACOLOGICA SINICA

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

(2011) Marie Tosolini et al.   CANCER RESEARCH

EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

(2011) Michela Garofalo et al.   NATURE MEDICINE

Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression

(2010) Xing-xiang Pu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation

(2009) Michela Garofalo et al.   CANCER CELL

Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer

(2009) Young-Kook Kim et al.   NUCLEIC ACIDS RESEARCH

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

(2008) Xi Chen et al.   CELL RESEARCH